Brokerages expect Colgate-Palmolive (NYSE:CL) to announce earnings per share of $0.66 for the current fiscal quarter, Zacks Investment Research reports. Six analysts have made estimates for Colgate-Palmolive’s earnings, with the highest EPS estimate coming in at $0.69 and the lowest estimate coming in at $0.62. Colgate-Palmolive reported earnings of $0.74 per share in the same quarter last year, which would suggest a negative year over year growth rate of 10.8%. The company is scheduled to issue its next earnings report before the market opens on Friday, April 26th.

On average, analysts expect that Colgate-Palmolive will report full-year earnings of $2.83 per share for the current fiscal year, with EPS estimates ranging from $2.81 to $2.85. For the next fiscal year, analysts anticipate that the business will post earnings of $3.01 per share, with EPS estimates ranging from $2.96 to $3.13. Zacks Investment Research’s EPS averages are an average based on a survey of sell-side research analysts that that provide coverage for Colgate-Palmolive.

Colgate-Palmolive (NYSE:CL) last released its earnings results on Friday, January 25th. The company reported $0.74 EPS for the quarter, topping analysts’ consensus estimates of $0.73 by $0.01. Colgate-Palmolive had a net margin of 15.44% and a return on equity of 25,268.29%. The firm had revenue of $3.81 billion during the quarter, compared to analyst estimates of $3.78 billion. During the same quarter in the previous year, the business earned $0.75 EPS. The business’s quarterly revenue was down 2.1% compared to the same quarter last year.

A number of analysts have commented on the stock. UBS Group lifted their target price on shares of Colgate-Palmolive from $71.00 to $75.00 and gave the stock a “buy” rating in a report on Friday, March 29th. Citigroup set a $68.00 target price on shares of Colgate-Palmolive and gave the stock a “hold” rating in a report on Tuesday, March 19th. BNP Paribas raised shares of Colgate-Palmolive from an “underperform” rating to a “neutral” rating and lifted their target price for the stock from $56.00 to $67.00 in a report on Monday, February 11th. Credit Suisse Group initiated coverage on shares of Colgate-Palmolive in a report on Wednesday, March 6th. They set an “underperform” rating for the company. Finally, Jefferies Financial Group reissued a “hold” rating and set a $61.00 price target on shares of Colgate-Palmolive in a research report on Friday, February 1st. Three research analysts have rated the stock with a sell rating, twelve have assigned a hold rating and four have given a buy rating to the company. Colgate-Palmolive currently has a consensus rating of “Hold” and an average target price of $65.73.

In related news, Director John T. Cahill sold 5,780 shares of the business’s stock in a transaction on Thursday, January 31st. The shares were sold at an average price of $64.46, for a total value of $372,578.80. Following the sale, the director now directly owns 27,820 shares of the company’s stock, valued at approximately $1,793,277.20. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Ian M. Cook sold 22,634 shares of the business’s stock in a transaction on Tuesday, February 19th. The shares were sold at an average price of $66.31, for a total transaction of $1,500,860.54. Following the completion of the sale, the chief executive officer now directly owns 1,162,793 shares in the company, valued at $77,104,803.83. The disclosure for this sale can be found here. Over the last three months, insiders have sold 85,450 shares of company stock worth $5,682,621. Insiders own 1.02% of the company’s stock.

A number of institutional investors and hedge funds have recently bought and sold shares of CL. Vanguard Group Inc. increased its stake in Colgate-Palmolive by 1.0% in the 3rd quarter. Vanguard Group Inc. now owns 73,520,894 shares of the company’s stock valued at $4,922,224,000 after buying an additional 734,860 shares during the last quarter. Vanguard Group Inc increased its stake in Colgate-Palmolive by 1.0% in the 3rd quarter. Vanguard Group Inc now owns 73,520,894 shares of the company’s stock valued at $4,922,224,000 after buying an additional 734,860 shares during the last quarter. BlackRock Inc. increased its stake in Colgate-Palmolive by 13.5% in the 4th quarter. BlackRock Inc. now owns 60,648,605 shares of the company’s stock valued at $3,609,804,000 after buying an additional 7,236,342 shares during the last quarter. Massachusetts Financial Services Co. MA increased its stake in Colgate-Palmolive by 3.2% in the 4th quarter. Massachusetts Financial Services Co. MA now owns 32,521,377 shares of the company’s stock valued at $1,935,674,000 after buying an additional 1,000,161 shares during the last quarter. Finally, Bank of New York Mellon Corp increased its stake in Colgate-Palmolive by 1.1% in the 3rd quarter. Bank of New York Mellon Corp now owns 20,359,199 shares of the company’s stock valued at $1,363,050,000 after buying an additional 223,814 shares during the last quarter. 76.13% of the stock is currently owned by institutional investors and hedge funds.

CL opened at $67.55 on Tuesday. The company has a debt-to-equity ratio of 32.25, a current ratio of 1.14 and a quick ratio of 0.76. Colgate-Palmolive has a 52 week low of $57.41 and a 52 week high of $72.61. The firm has a market cap of $58.44 billion, a price-to-earnings ratio of 22.74, a price-to-earnings-growth ratio of 4.38 and a beta of 0.79.

The company also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Friday, April 19th will be given a dividend of $0.43 per share. This represents a $1.72 dividend on an annualized basis and a dividend yield of 2.55%. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.42. The ex-dividend date is Wednesday, April 17th. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 56.57%.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.

Read More: What is a back-end load?

Get a free copy of the Zacks research report on Colgate-Palmolive (CL)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.